132 related articles for article (PubMed ID: 8949349)
1. [Lysinuric dibasic protein intolerance: characteristic aspects of bone marrow involvement].
Doireau V; Fenneteau O; Duval M; Perelman S; Vilmer E; Touati G; Schlegel N; Ogier de Baulny H
Arch Pediatr; 1996 Sep; 3(9):877-80. PubMed ID: 8949349
[TBL] [Abstract][Full Text] [Related]
2. [Lysinuric protein intolerance].
Behbehani AW; Gahr M; Schröter W
Monatsschr Kinderheilkd; 1983 Nov; 131(11):784-7. PubMed ID: 6420670
[TBL] [Abstract][Full Text] [Related]
3. Intermittent hemophagocytic lymphohistiocytosis is a regular feature of lysinuric protein intolerance.
Duval M; Fenneteau O; Doireau V; Faye A; Emilie D; Yotnda P; Drapier JC; Schlegel N; Sterkers G; de Baulny HO; Vilmer E
J Pediatr; 1999 Feb; 134(2):236-9. PubMed ID: 9931537
[TBL] [Abstract][Full Text] [Related]
4. [The dibasic amino acid metabolic disorders].
Shimizu H
Nihon Rinsho; 1992 Jul; 50(7):1555-60. PubMed ID: 1404883
[TBL] [Abstract][Full Text] [Related]
5. Bone marrow hemophagocytosis and immunological abnormalities in a patient with lysinuric protein intolerance.
Gürsel T; Koçak U; Tümer L; Hasanoğlu A
Acta Haematol; 1997; 98(3):160-2. PubMed ID: 9352748
[TBL] [Abstract][Full Text] [Related]
6. Unusual association between lysinuric protein intolerance and moyamoya vasculopathy.
Ghilain V; Wiame E; Fomekong E; Vincent MF; Dumitriu D; Nassogne MC
Eur J Paediatr Neurol; 2016 Sep; 20(5):777-81. PubMed ID: 27321952
[TBL] [Abstract][Full Text] [Related]
7. [Lysinuric protein intolerance: a severe hyperammonemia secondary to l-arginine deficiency (author's transl)]].
Coude FX; Ogier H; Charpentier C; Cathelineau L; Grimber G; Parvy P; Saudubray JM; Frezal J
Arch Fr Pediatr; 1981 Dec; 38 Suppl 1():829-35. PubMed ID: 6800334
[TBL] [Abstract][Full Text] [Related]
8. Update on Lysinuric Protein Intolerance, a Multi-faceted Disease Retrospective cohort analysis from birth to adulthood.
Mauhin W; Habarou F; Gobin S; Servais A; Brassier A; Grisel C; Roda C; Pinto G; Moshous D; Ghalim F; Krug P; Deltour N; Pontoizeau C; Dubois S; Assoun M; Galmiche L; Bonnefont JP; Ottolenghi C; de Blic J; Arnoux JB; de Lonlay P
Orphanet J Rare Dis; 2017 Jan; 12(1):3. PubMed ID: 28057010
[TBL] [Abstract][Full Text] [Related]
9. Oral supplementation corrects plasma lysine concentrations in lysinuric protein intolerance.
Lukkarinen M; Näntö-Salonen K; Pulkki K; Aalto M; Simell O
Metabolism; 2003 Jul; 52(7):935-8. PubMed ID: 12870174
[TBL] [Abstract][Full Text] [Related]
10. Lysinuric protein intolerance presenting deficiency of argininosuccinate synthetase.
Ono N; Kishida K; Tokumoto K; Watanabe M; Shimada Y; Yoshinaga J; Fujii M
Intern Med; 1992 Jan; 31(1):55-9. PubMed ID: 1568044
[TBL] [Abstract][Full Text] [Related]
11. Hyperexcretion of homocitrulline in a Malaysian patient with lysinuric protein intolerance.
Habib A; Md Yunus Z; Azize NA; Ch'ng GS; Ong WP; Chen BC; Hsu HT; Wong KJ; Pitt J; Ngu LH
Eur J Pediatr; 2013 Sep; 172(9):1277-81. PubMed ID: 23358709
[TBL] [Abstract][Full Text] [Related]
12. Lysinuric protein intolerance characterized by bone marrow abnormalities and severe clinical course.
Parenti G; Sebastio G; Strisciuglio P; Incerti B; Pecoraro C; Terracciano L; Andria G
J Pediatr; 1995 Feb; 126(2):246-51. PubMed ID: 7844671
[TBL] [Abstract][Full Text] [Related]
13. Intravenous immune globulin in lysinuric protein intolerance.
Dionisi-Vici C; De Felice L; el Hachem M; Bottero S; Rizzo C; Paoloni A; Goffredo B; Sabetta G; Caniglia M
J Inherit Metab Dis; 1998 Apr; 21(2):95-102. PubMed ID: 9584260
[TBL] [Abstract][Full Text] [Related]
14. Hyperammonemia in lysinuric protein intolerance.
Kato T; Mizutani N; Ban M
Pediatrics; 1984 Apr; 73(4):489-92. PubMed ID: 6424086
[TBL] [Abstract][Full Text] [Related]
15. Effect of lysine infusion on urea cycle in lysinuric protein intolerance.
Lukkarinen M; Näntö-Salonen K; Pulkki K; Mattila K; Simell O
Metabolism; 2000 May; 49(5):621-5. PubMed ID: 10831173
[TBL] [Abstract][Full Text] [Related]
16. Imbalance of plasma amino acids, metabolites and lipids in patients with lysinuric protein intolerance (LPI).
Kurko J; Tringham M; Tanner L; Näntö-Salonen K; Vähä-Mäkilä M; Nygren H; Pöhö P; Lietzen N; Mattila I; Olkku A; Hyötyläinen T; Orešič M; Simell O; Niinikoski H; Mykkänen J
Metabolism; 2016 Sep; 65(9):1361-75. PubMed ID: 27506743
[TBL] [Abstract][Full Text] [Related]
17. The first Korean case of lysinuric protein intolerance: presented with short stature and increased somnolence.
Ko JM; Shin CH; Yang SW; Seong MW; Park SS; Song J
J Korean Med Sci; 2012 Aug; 27(8):961-4. PubMed ID: 22876067
[TBL] [Abstract][Full Text] [Related]
18. Lysinuric protein intolerance.
Simell O; Perheentupa J; Rapola J; Visakorpi JK; Eskelin LE
Am J Med; 1975 Aug; 59(2):229-40. PubMed ID: 1155480
[TBL] [Abstract][Full Text] [Related]
19. Impaired phagocytosis in macrophages from patients affected by lysinuric protein intolerance.
Barilli A; Rotoli BM; Visigalli R; Bussolati O; Gazzola GC; Gatti R; Dionisi-Vici C; Martinelli D; Goffredo BM; Font-Llitjós M; Mariani F; Luisetti M; Dall'Asta V
Mol Genet Metab; 2012 Apr; 105(4):585-9. PubMed ID: 22325938
[TBL] [Abstract][Full Text] [Related]
20. Lysinuric protein intolerance: a two-year trial of dietary supplementation therapy with citrulline and lysine.
Rajantie J; Simell O; Rapola J; Perheentupa J
J Pediatr; 1980 Dec; 97(6):927-32. PubMed ID: 6777479
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
